A5087170445- COVID-19 Clinical Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- Long-Term Effects of COVID-19
- Platelet Disorders and Treatments
- Heparin-Induced Thrombocytopenia and Thrombosis
- Venous Thromboembolism Diagnosis and Management
- Intramuscular injections and effects
- Adipokines, Inflammation, and Metabolic Diseases
- Pregnancy and preeclampsia studies
Royal College of Surgeons in Ireland
2019-2022
Tallaght University Hospital
2022
Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory Syndrome 2 (SARS-CoV-2), has affected over 30 million globally to date. Although high rates of venous thromboembolism and evidence COVID-19-induced endothelial dysfunction have been reported, precise aetiology increased thrombotic risk associated with COVID-19 infection remains be fully elucidated. Therefore, we assessed clinical platelet parameters circulating activity in patients severe nonsevere COVID-19. An...
Abstract Background Coronavirus disease 2019 (COVID-19), caused by novel coronavirus SARS-CoV-2, has to date affected over 13.3 million globally. Although high rates of venous thromboembolism and evidence COVID-19-induced endothelial dysfunction have been reported, the precise aetiology increased thrombotic risk associated with COVID-19 infection remains be fully elucidated. Objectives Here, we assessed clinical platelet parameters circulating activity in patients severe non-severe COVID-19....
Vaccine-induced thrombotic thrombocytopenia (VITT) post SARS-CoV-2 vaccination is characterized by and severe thrombosis. Platelet function during patient recovery in the medium-/long-term has not been investigated fully. Here, we undertook a 3-month study, assessing of VITT platelet morphology, granule content dense-granule release at two distinct time points recovery. A 61 year-old female was admitted to hospital 15 days ChAdOx1 nCov-19 vaccination. Hematological parameters peripheral...